Clinical Trials Browser

Phase 3 × trastuzumab deruxtecan × Tumor-Agnostic × Clear all

NCT06174987 2025-10-15

A Study to Provide Continued Access to and Assess Long-Term Safety of the Study Drug(s)

Phase 3 Recruiting

Neoplasm Metastasis